Biolase, Inc. (NASDAQ:BIOL) is set to announce third quarter earning results on Thursday 12th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, BIOL to report 3Q20 loss of $ 0.05 per share.
For the full year, analysts anticipate top line of $ 21.74 million, while looking forward to loss of $ 0.35 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 6.40 million ~ $ 6.60 million
Click Here For More Historical Outlooks Of Biolase, Inc.
Previous Quarter Performance
Biolase, Inc. revealed loss for the second quarter of $ 0.12 per share, from the revenue of $ 2.94 million. The quarterly revenues declined 69.02 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.08 per share from $ 5.71 million in revenue. The bottom line results missed street analysts by $ 0.04 or 50 percent, at the same time, top line results fell short of analysts by $ 2.77 million or 48.51 percent.
Stock Performance
Shares of Biolase, Inc. traded low $ -0.01 or -2.17 percent on Wednesday, reaching $ 0.30 with volume of 904.00 thousand shares. Biolase, Inc. has traded high as $ 0.31 and has cracked $ 0.28 on the downward trend
The closing price of $ 0.30, representing a 42.86 % increase from the 52 week low of $ 0.21 and a 68.75 % decrease over the 52 week high of $ 0.96.
The company has a market capital of $ 27.38 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Recent Analyst recommendations
- On 14th October 2020, initiated by Maxim Group at Buy rating, with $ 1.00 target price.
Conference Call
Biolase, Inc. will be hosting a conference call at 4:30 PM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community. The participants may dial, (800) 367-2403 Toll Free or +1 334-777-6978 Toll Number, and the passcode is 9286776 in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website www.biolase.com
BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the worldwide. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications.
